Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)
EUR 45.28
(1.71%)
EUR 45.28
(1.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 116.34 Million EUR | 8.95% |
| 2022 | 106.78 Million EUR | 17.24% |
| 2021 | 91.07 Million EUR | 5.25% |
| 2020 | 86.53 Million EUR | -0.57% |
| 2019 | 87.02 Million EUR | 17.05% |
| 2018 | 74.34 Million EUR | 16.41% |
| 2017 | 63.86 Million EUR | -3.41% |
| 2016 | 66.12 Million EUR | 6.05% |
| 2015 | 62.35 Million EUR | -2.24% |
| 2014 | 63.78 Million EUR | 11.75% |
| 2013 | 57.07 Million EUR | -12.44% |
| 2012 | 65.18 Million EUR | 1.2% |
| 2011 | 64.41 Million EUR | 11.44% |
| 2010 | 57.79 Million EUR | 13.05% |
| 2009 | 51.12 Million EUR | 49.66% |
| 2008 | 34.15 Million EUR | 31.63% |
| 2007 | 25.95 Million EUR | 8.6% |
| 2006 | 23.89 Million EUR | 29.23% |
| 2005 | 18.49 Million EUR | 13.4% |
| 2004 | 16.3 Million EUR | 21.19% |
| 2003 | 13.45 Million EUR | -11.86% |
| 2002 | 15.26 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 34.89 Million EUR | 31.6% |
| 2024 Q2 | 38.12 Million EUR | 9.26% |
| 2024 Q3 | 70.1 Million EUR | -10.81% |
| 2023 FY | 116.34 Million EUR | 8.95% |
| 2023 Q4 | 26.51 Million EUR | -18.36% |
| 2023 Q3 | 32.48 Million EUR | 8.47% |
| 2023 Q2 | 29.94 Million EUR | 9.17% |
| 2023 Q1 | 27.42 Million EUR | 22.74% |
| 2022 Q1 | 26.19 Million EUR | 21.36% |
| 2022 FY | 106.78 Million EUR | 17.24% |
| 2022 Q4 | 22.34 Million EUR | -23.23% |
| 2022 Q2 | 29.13 Million EUR | 11.24% |
| 2022 Q3 | 29.1 Million EUR | -0.1% |
| 2021 FY | 91.07 Million EUR | 5.25% |
| 2021 Q1 | 23.85 Million EUR | -10.85% |
| 2021 Q2 | 24.23 Million EUR | 1.58% |
| 2021 Q3 | 21.41 Million EUR | -11.63% |
| 2021 Q4 | 21.58 Million EUR | 0.79% |
| 2020 Q3 | 18.86 Million EUR | -1.41% |
| 2020 FY | 86.53 Million EUR | -0.57% |
| 2020 Q1 | 21.78 Million EUR | 7.34% |
| 2020 Q4 | 26.75 Million EUR | 41.87% |
| 2020 Q2 | 19.13 Million EUR | -12.19% |
| 2019 Q3 | 21.01 Million EUR | -13.43% |
| 2019 Q2 | 24.27 Million EUR | 13.25% |
| 2019 Q1 | 21.43 Million EUR | 12.11% |
| 2019 FY | 87.02 Million EUR | 17.05% |
| 2019 Q4 | 20.29 Million EUR | -3.42% |
| 2018 Q2 | 21.16 Million EUR | 39.31% |
| 2018 FY | 74.34 Million EUR | 16.41% |
| 2018 Q4 | 19.12 Million EUR | 1.34% |
| 2018 Q1 | 15.19 Million EUR | -5.28% |
| 2018 Q3 | 18.86 Million EUR | -10.84% |
| 2017 Q1 | 17.61 Million EUR | -1.21% |
| 2017 FY | 63.86 Million EUR | -3.41% |
| 2017 Q4 | 16.03 Million EUR | 1.91% |
| 2017 Q3 | 15.73 Million EUR | 8.71% |
| 2017 Q2 | 14.47 Million EUR | -17.8% |
| 2016 FY | 66.12 Million EUR | 6.05% |
| 2016 Q2 | 14.85 Million EUR | -13.88% |
| 2016 Q3 | 16.18 Million EUR | 8.92% |
| 2016 Q1 | 17.25 Million EUR | 5.56% |
| 2016 Q4 | 17.82 Million EUR | 10.15% |
| 2015 Q3 | 15.36 Million EUR | 9.37% |
| 2015 FY | 62.35 Million EUR | -2.24% |
| 2015 Q4 | 16.34 Million EUR | 6.36% |
| 2015 Q2 | 14.05 Million EUR | -15.29% |
| 2015 Q1 | 16.58 Million EUR | -4.49% |
| 2014 Q2 | 15.52 Million EUR | 1.26% |
| 2014 Q1 | 15.33 Million EUR | 15.83% |
| 2014 FY | 63.78 Million EUR | 11.75% |
| 2014 Q3 | 15.55 Million EUR | 0.15% |
| 2014 Q4 | 17.36 Million EUR | 11.67% |
| 2013 FY | 57.07 Million EUR | -12.44% |
| 2013 Q1 | 12.17 Million EUR | -33.71% |
| 2013 Q2 | 15.37 Million EUR | 26.29% |
| 2013 Q3 | 16.28 Million EUR | 5.93% |
| 2013 Q4 | 13.23 Million EUR | -18.71% |
| 2012 FY | 65.18 Million EUR | 1.2% |
| 2012 Q1 | 16.31 Million EUR | -0.29% |
| 2012 Q3 | 15.47 Million EUR | 3.04% |
| 2012 Q4 | 18.36 Million EUR | 18.64% |
| 2012 Q2 | 15.02 Million EUR | -7.92% |
| 2011 Q4 | 16.36 Million EUR | 1.65% |
| 2011 FY | 64.41 Million EUR | 11.44% |
| 2011 Q3 | 16.09 Million EUR | 3.27% |
| 2011 Q2 | 15.58 Million EUR | -4.72% |
| 2011 Q1 | 16.36 Million EUR | 12.68% |
| 2010 Q4 | 14.52 Million EUR | -2.98% |
| 2010 FY | 57.79 Million EUR | 13.05% |
| 2010 Q1 | 14.09 Million EUR | 31.06% |
| 2010 Q2 | 14.22 Million EUR | 0.92% |
| 2010 Q3 | 14.96 Million EUR | 5.25% |
| 2009 Q2 | 15.02 Million EUR | 19.45% |
| 2009 Q1 | 12.58 Million EUR | 0.0% |
| 2009 FY | 51.12 Million EUR | 49.66% |
| 2009 Q4 | 10.75 Million EUR | -15.77% |
| 2009 Q3 | 12.76 Million EUR | -15.07% |
| 2008 FY | 34.15 Million EUR | 31.63% |
| 2007 FY | 25.95 Million EUR | 8.6% |
| 2006 FY | 23.89 Million EUR | 29.23% |
| 2005 FY | 18.49 Million EUR | 13.4% |
| 2004 FY | 16.3 Million EUR | 21.19% |
| 2003 FY | 13.45 Million EUR | -11.86% |
| 2002 FY | 15.26 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| aap Implantate AG | 9.73 Million EUR | -1094.855% |
| Drägerwerk AG & Co. KGaA | 1.45 Billion EUR | 92.03% |
| Drägerwerk AG & Co. KGaA | 1.45 Billion EUR | 92.03% |
| elexxion AG | 58.54 Thousand EUR | -198613.876% |
| Geratherm Medical AG | 17.19 Million EUR | -576.598% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 98.438% |
| Stratec SE | 64.84 Million EUR | -79.417% |
| Siemens Healthineers AG | 8.46 Billion EUR | 98.626% |